CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 122 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q1 2023. The put-call ratio across all filers is 1.34 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $201 | -31.4% | 9,218 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $293 | +48.7% | 9,218 | +13.9% | 0.00% | 0.0% |
| Q1 2023 | $197 | -34.6% | 8,096 | -15.3% | 0.00% | -33.3% |
| Q4 2022 | $301 | -99.9% | 9,558 | +9.6% | 0.00% | +50.0% |
| Q3 2022 | $247,000 | +8.8% | 8,724 | +1.6% | 0.00% | 0.0% |
| Q2 2022 | $227,000 | -2.2% | 8,586 | +29.4% | 0.00% | 0.0% |
| Q1 2022 | $232,000 | -49.8% | 6,633 | -53.5% | 0.00% | 0.0% |
| Q4 2021 | $462,000 | +120.0% | 14,260 | +100.3% | 0.00% | 0.0% |
| Q3 2021 | $210,000 | – | 7,119 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |